Your browser doesn't support javascript.
loading
Enhancing natural killer cell function with gp41-targeting bispecific antibodies to combat HIV infection.
Ramadoss, Nitya S; Zhao, Nancy Q; Richardson, Barbra A; Grant, Philip M; Kim, Peter S; Blish, Catherine A.
Affiliation
  • Ramadoss NS; Department of Biochemistry.
  • Zhao NQ; Stanford ChEM-H, Stanford University, Stanford, California, USA.
  • Richardson BA; Department of Medicine, Division of Infectious Diseases and Geographic Medicine.
  • Grant PM; Program in Immunology, School of Medicine, Stanford University, Stanford, California.
  • Kim PS; Department of Biostatistics, University of Washington, Seattle, Washington.
  • Blish CA; Department of Medicine, Division of Infectious Diseases and Geographic Medicine.
AIDS ; 34(9): 1313-1323, 2020 07 15.
Article in En | MEDLINE | ID: mdl-32287071
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / HIV Antibodies / HIV Envelope Protein gp41 / HIV Infections / Antibodies, Bispecific / Antibody-Dependent Cell Cytotoxicity Limits: Humans Language: En Journal: AIDS Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2020 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / HIV Antibodies / HIV Envelope Protein gp41 / HIV Infections / Antibodies, Bispecific / Antibody-Dependent Cell Cytotoxicity Limits: Humans Language: En Journal: AIDS Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2020 Document type: Article Country of publication: United kingdom